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Abstract.  The Bcl-2 protein is an important regulator 
of programmed cell death, but the biochemical mecha- 
nism by which this protein prevents apoptosis remains 
enigmatic.  Recently, Bcl-2 has been reported to physi- 
cally interact with a member of the Ras superfamily of 
small GTPases, p23-R-Ras. To examine the functional 
significance of R-Ras for regulation of cell death path- 
ways, the IL-3-dependent cells 32D.3 and FL5.12 
were stably transfected with expression plasmids 
encoding an activated form (38 Glycine --- Valine)  of 
R-Ras protein.  R-Ras(38V)-producing 32D.3 and 
FL5.12 cells experienced increased rates of apoptotic 
cell death relative to control transfected cells when 
deprived of IL-3.  Analysis of several independent 
clones of transfected 32D.3 cells revealed a correlation 
between higher levels of R-Ras protein and faster rates 
of cell death upon withdrawal of IL-3 from cultures. 
32D.3 cells cotransfected with R-Ras(38V) and Bcl-2 
exhibited prolonged cell survival in the absence of 
IL-3, equivalent to 32D.3 cells transfected with Bcl-2 
expression plasmids alone.  R-Ras(38V) also increased 
rates of cell death in serum-deprived NIH-3T3 cells, 
and Bcl-2 again abrogated most of this effect. The ra- 
tio of GTP and GDP bound to R-Ras(38V) was not 
significantly different in control 32D.3 cells vs those 
that overexpressed Bcl-2, indicating that Bcl-2 does 
not abrogate R-Ras-mediated effects on cell death by 
altering R-Ras GDP/GTP regulation.  Moreover, 
purified Bcl-2 protein had no effect on the GTPase 
activity of recombinant wild-type R-Ras in vitro. 
When expressed in St9 cells using recombinant baculo- 
viruses, R-Ras(38V) bound to and induced activation 
of Raf-1 kinase irrespective of whether Bcl-2 was 
coproduced in these cells, suggesting that Bcl-2 does 
not nullify R-Ras effects by interfering with R-Ras- 
mediated activation of Raf-1 kinase.  Taken  together, 
these findings suggest that R-Ras enhances the activity 
of a cell death pathway in growth factor-deprived cells 
and imply that Bcl-2 acts downstream of R-Ras to pro- 
mote cell survival. 
S 
F.VEX~AL genes have been identified  that participate  as 
either inducers or repressors of programmed cell death 
and apoptosis. Among these is bcl-2 (B-cell lympho- 
ma-2) ~, a blocker of cell death  which was first discovered 
by virtue of its  involvement  in  the t(14;18) chromosomal 
translocations  found in the majority of non-Hodgkin's B cell 
lymphomas (Tsujimoto  et al.,  1985; Tsujimoto and Croce, 
1986). Dysregulation  of  bcl-2 expression contributes to neo- 
plastic cell expansion by preventing normal cell turnover due 
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to programmed cell death, rather than by accelerating  rates 
of cellular proliferation  (Vaux et al., 1988; McDonnell et al., 
1989; Katsumata  et al.,  1992).  Gene transfer  studies  have 
shown that elevations in Bcl-2 protein levels can provide pro- 
tection  against  cell death  induced by a broad spectrum of 
stimuli,  suggesting that this protein regulates a distal step in 
a final common pathway for apoptotic cell death (for review 
see Reed, 1994). Furthermore, elements of this pathway ap- 
pear to be well conserved throughout evolution in that the 
human Bcl-2 protein can also provide cell death protection 
to insect ceils, worms, and yeast under at least some circum- 
stances (Alnemri et al., 1992; Vaux et al., 1992; Kane et al., 
1993; Sato et al.,  1994; Hengartner and Horvitz,  1994). 
The biochemical mechanism of action of the Bcl-2 protein 
remains enigmatic,  principally  because its predicted amino 
acid sequence shares  no  significant  homology with other 
proteins whose functions are known. In mammalian  species, 
the bcl-2 gene encodes a 25-26-kD intracellular  protein that 
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boxy terminus, accounting for its posttranslational insertion 
into membranes (Chen-Levy and Cleary, 1990).  The intra- 
cellular locations where the Bcl-2 protein resides include 
predominantly the outer mitochondrial membrane, nuclear 
envelope, and parts of the ER (Krajewski et al., 1993; Jacob- 
son et al., 1993; de Jong et al., 1994; Lithgow et al., 1994). 
Electron microscopic data suggest that Bcl-2  may be  as- 
sociated at least in part with nuclear pore complexes and mi- 
tochondrial junctional complexes, where the inner and outer 
membranes of these DNA-containing organelles come into 
contact  and  where  various  transport  phenomena  occur 
(Krajewski et al.,  1993;  de Jong et al.,  1994).  Consistent 
with this localization, evidence has recently been obtained 
suggesting that Bcl-2 may impair the translocation of the p53 
tumor suppressor as well as the Cdc-2 and Cdk-2 kinases 
into nuclei (Ryan et al., 1994; Meikrantz et al., 1994). How- 
ever, Bcl-2 can also provide protection against apoptotic-like 
phenomena that occur in the cytosol in the absence of a nu- 
cleus, based on studies involving enucleated cytoplasts and 
a cell-free apoptosis assay (Jacobson et al., 1994; Newmeyer 
et al., 1994). Furthermore, evidence has been obtained sug- 
gesting that Bcl-2 may regulate intracellular Ca  2÷ homeo- 
stasis or an antioxidant pathway (Baffy et al., 1993; Lam et 
al.,  1994;  Kane et al.,  1993;  Hockenbery et al.,  1993). 
Nevertheless, at this point, no direct cause and effect data 
exist  that  conclusively  link  Bcl-2  to  protein  transport, 
Ca  2+ regulation, antioxidant enzymes, or other biochemical 
events. 
Recently, Bcl-2 has been reported to physically associate 
with p72  Raf-1, a  serine/threonine-specific protein kinase 
(Wang et al., 1994), and p23-R-Ras (Fernandez-Sarabia and 
Bischoff, 1993), a GTPase member of the Ras family (Lowe 
et al., 1987), suggesting that this apoptosis-blocking protein 
may control a signal transduction pathway located in the vi- 
cinity of mitochondrial, nuclear, and perhaps other intracel- 
lular  membranes,  instead  of the  plasma  membrane.  In 
cotransfection studies, the combination of elevations in Bcl-2 
protein levels and Raf-1 kinase activity were shown to pro- 
vide  synergistic  protection  from  cell  death  induced  by 
growth factor withdrawal from a diploid hematopoietic cell 
line (Wang  et al.,  1994).  The function of R-Ras  and the 
significance of its interaction with Bcl-2 however have not 
been explored where regulation of cell death is concerned. 
In Rat-1 fibroblasts, R-Ras and mutant versions of this pro- 
tein that presumably remain mostly in an active GTP-bound 
state due to impaired GTPase activity were reported to lack 
transforming activity, unlike oncogenic mutants of their p21- 
Ha-Ras counterparts (Lowe and Goeddel,  1987).  In NIH- 
3T3 fibroblasts, however, versions of R-Ras with mutations 
at condons 38 or 87, analogous to the oncogenic position 12 
and 61 mutants of Ha-Ras, confer ability to proliferate in low 
serum, form colonies in soft agar, and form tumors in nude 
mice, as well as inducing morphological transformation to 
variable extents (Cox et al., 1994; Saez et al., 1994). Similar 
to Ha-Ras proteins, R-Ras has also been reported to bind to 
Raf-1 kinase in vitro in a GTP-dependent fashion, stimulate 
activation of the  mitogen-activated protein  kinases  p44- 
ERK-1 and p42-ERK-2,  and induce  transcription of ras- 
responsive reporters in a Raf-dependent manner in NIH-3T3 
cells (Cox et al., 1994; Rey et al., 1994; Spaargaren et al., 
1994). These similarities to Ha-Ras notwithstanding, R-Ras 
does not induce maturation of Xenopus oocytes or differenti- 
ation of PC12 cells (Rey et al., 1994). Taken together, there- 
fore, the data available to date indicate that while some over- 
lap in the biochemical and cellular functions of Ha-Ras and 
R-Ras exist, these proteins appear to play different  biological 
roles. Here we present evidence that one of the roles played 
by R-Ras can be to promote apoptotic cell death in the setting 
of growth factor withdrawal. 
Materials and Methods 
Expression Plasmids 
The plasmids pEXV-R-Ras(WT) and pEXV-R-Ras(38V) contain R-Ras and 
R-Ras(38V)  cDNAs under the control of a  SV40 promoter/enhancer (gift 
of Alan Hall) (Rey et al.,  1994).  R-Ras eDNA sequences were liberated 
from these pEXV plasmids by digestion with EcoRI and subcloned into the 
EcoRI site of pGEX-3X (Pharmacia LKB Biotechnoiogy, Piscataway,  N J) 
for production of GST-R-Ras  and GST-R-Ras(38V)  proteins in E.  coli. 
These cDNAs were also subcloned into the EcoRI site of the baculovirus 
transfer vector pVL1393  and  recombinant baculoviruses were prepared 
using the BaculoGold system (PharMingen, Inc., San Diego, CA). 
Cell Transfections 
32D.3 cells (Mavillo et al., 1989) were maintained essentially as described 
(Baffy et al.,  1993;  Tanaka  et al.,  1993) at 0.05-1  ×  106 cells per ml in 
Iscove's modified Dulbecco medium (IMDM) (Irvine Scientific, Inc., Ir- 
vine, CA) supplemented with 1 mM L-glutamine, 100 U/nil penicillin-G, 
100  /zg/ml  streptomycin,  10%  (vol/vol) heat-inactivated FCS  and  20% 
(vol/vol) of conditioned medium from the IL-3-producing cell line WEHI- 
3B. FL5.12 cells were similarly maintained except that RPMI-1640 medium 
was used and 25 mm Hepes (pH 7.4) and 50 #M/3-mercaptoethanol were 
added. A  combination of 20 #g of PvuI-linearized pEXV-R-Ras(WT) or 
pEXV-R-Ras(38V) or pEXV parental vector with 5 #g of Ndel-linearized 
pZip-Neo or pZip-Bcl-2 plasmid DNA (Miyashita and Reed,  1992)  was 
mixed with 5  x  106 of 32D.3 or FL5.12 cells in 0.8 ml of Dulbecco's PBS 
(pH 7.4) on ice. For 32D.3  cells, plasmid DNAs were then introduced by 
electroporation using a double pulse consisting of 2,000 V/cm; 40 #F; 74 
ohms followed by 250 V/cm; 1,500 #F; 74 ohms, using an apparatus from 
EquiBio, Inc. (Angleur, Belgium) (CellJect), and 2 d later cells were se- 
lected in medium containing IL-3  and 800 #g/ml (3418  (GIBCO BRL, 
Gaithersburg, MD). FL5.12 cells similarly received a single pulse of 500 
V/cm at 900 ttF, and were selected in medium containing 1 mg/ml G418. 
For subcloning, G418-resistant cells were seeded at an average of 0.5 cells 
per well in 0.1 ml of IL-3-containing medium in 96-well plates. 
NIH-3T3 cells were grown in 100-mm dishes in DMEM (MediaTech, 
Inc.,  Herndon,  VA) supplemented with antibiotics, glutamine, and  10% 
(vol/vol) calf serum. Cells were transfected by a calcium-phosphate precipi- 
tation method and selected in 400 #g/ml G418,  essentially as described 
(Cox et al.,  1994). 
Cell Viability and Apoptosis Assays 
32D.3 and FL5.12 cells (2 ×  106) were washed three times with IMDM or 
RPMI and cultured in 10 ml IMDM or RPMI containing 10% FCS without 
IL-3 for various times. Cells in culture supernatants were recovered by cen- 
trifugation and pooled with cells that were detached from flasks using HBSS 
containing 0.02%  EDTA.  The percentage of viable cells was then deter- 
mined by trypan blue dye exclusion, counting a minimum of 200 cells each 
for triplicate samples. In some cases, after ,'~1 d of culture without IL-3, 
32D.3  cells were recovered from flasks as above, washed in PBS (pH 7.4), 
and fixed in 3.7%  formaldehyde in PBS for l0 min at room temperature. 
After three washes in PBS, cells were resuspended in PBS containing 0.1 
~g/ml of 4',6-diamindino-2-phenylinodole  (DAPI) for 15 min, washed sev- 
eral times in PBS, and examined using a Nikon fluorescence microscope. 
Alternatively, 106 cells were fixed on ice in PBS containing 30% ethanol, 
and  the  DNA  of  RNAse-treated  cells  was  subsequently  stained  with 
propidium iodide (PI) as described previously (Wang et ai.,  1994).  DNA 
content analysis was accomplished by flow cytometry using a FACStar-Plus 
(Becton-Dickinson Immunocytometry Sys., Mountain View, CA). 
NIH-3T3 cells were seeded at 5  ×  104 cells per well of 24-well plates 
in 0.5 mi DMEM complete medium. The next day, cells were washed in 
DMEM without serum and cultured for 48 h without serum. Floating apop- 
totic cells were gently washed off using PBS and the remaining viable at- 
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microscope. Alternatively, 5  x  104 cells were seed into 24-well plates and, 
after culturing overnight, the cells were washed once in DMEM without se- 
rum and cultured without serum for 48 h. The plates were centrifuged at 
400 g for 5 min to pellet floating apoptotic cells, and after washing in PBS 
and fixing in 3.7%  formaldehyde in PBS, the cells were stained with 0.1 
#g/ml DAPI and the numbers of normal and apoptotic cells were counted 
using a  UV-microscope. 
Preparation of  R-Ras Antibodies 
A polyclonal antiserum was produced in rabbits using as a immunogen a 
synthetic  peptide  (NH2-Cys-Arg-Gly-Arg-Pro-Arg-Gly-Gly-Gly-Pro-Gly- 
Pro-Arg-Asp-Pro-Pro-Pro-Gly-Glu-Thr-His-Tyr-amide) corresponding  to 
amino acids 11-31 of the mouse R-Ras protein with a NH2-terminai cys- 
teine appended to facilitate conjugation to maleimide-activated Keyhole 
Limpet Hemocyanin (KLH) (Pierce, Rockford, IL), using methods essen- 
tially as described previously (Reed et al.,  1991). 
GTPase Assays and Nucleotide-binding Studies 
To produce the GST-R-Ras  and GST-R-Ras(38V)  proteins, DH5-a strain 
E.  coli containing pGEX-3X-R-Ras or pGEX-3X-R-Ras(38V) were cultured 
at 37°C in 1 liter of LB medium containing 50 #g/rnl ampicillin until the 
O.D.59onrn reached 0.6 to 1.0. IPTG was then added to 0.2 mM and the cul- 
tures were continued for 5 h at 25°C. Bacteria were recovered by centrifuga- 
tion, washed in ice-cold PBS, and resuspended in 10 ml of PBS containing 
1% Triton X-100, 20 #g/ml aprotinin, 1 mM PMSE 1 mg/ml lysozyme. Af- 
ter 10 min at 37°C, the cells were sonicated on ice, using 3 pulses of 30 s 
each from a 5-mm microtip sonicator (model X L2020; Heat Systems, Inc., 
Farmingdale, NY). Cell lysates were centrifuged at 15,000 g for 15 rain, 
and the resulting supernatant was applied to a 2-ml column of glutathione- 
Sepharose (Pharmacia LKB Biotechnology). The column was washed with 
10-bed volumes of ice-cold PBS containing 1 mM PMSF and 20 #g/ml 
aprotinin. GST-fusion proteins were then eluted in 2 bed volumes of 50 mM 
Tris (pH 8.0) containing 5 mM glutathione. After dialysis in 20 mM Tris 
(pH 7.5),  1 mM DTT,  0.1 mM PMSE  10%  glycerol, ,~10 #g of affinity- 
purified proteins were incubated for 10 min at 30°C in 25 t~l of 50 mM Tris 
(pH 7.5),  50 mM NaCI, 0.1 mM DTT,  10 txM [32p]~'-GTP.  The samples 
were then placed on ice and MgCI2 was added to achieve a final concentra- 
tion of 5 mM. GTPase assays (Garrett et al., 1989) were then initiated by 
placing at 30°C 1/zg of [32p]GTP-loaded  proteins in 50 mM "Iris (pH 7.5), 
0.1 mM DTT,  5 mM MgCI:,  1 mg/ml BSA,  1 mM GTE with or without 
0.5 t~g of purified Bcl-2 protein. At various times, 5/~1 aliquots were diluted 
in 1 rni of 50 mM Tris (pH 7.5),  0.1 mM DTT,  5 mM MgC12 and filtered 
through nitrocellulose (BA85 filters; Schleicher &  Schuell, Inc., Keene, 
NH). Filters were washed with 10 ml of the same solution, dried, and sub- 
jected to scintillation counting. Bcl-2 protein was immunoaflinity purified 
by the method of Haldar et al. (1994) from Sf9 cells infected with a recom- 
binant bcl-2 baculovirus using the monoclonal antibody 4D7  (Reed et al., 
1992). 
To measure relative amounts of GTP and GDP bound to R-Ras, 32D-R- 
Ras(38V) or 32D-R-Ras(38V)/Bcl-2 cells were cultured for 5 h  in phos- 
phate-free RPMI-1640  medium  containing  10%  dialyzed FCS  and  0.2 
mCi/ml 32po4 (ICN Radiochemicals, Inc., Costa Mesa, CA). After wash- 
ing three times in ice-cold PBS, cells were lysed for 10 min on ice in 0.5 
ml of 50 mM Hepes (pH 7.5),  100 mM NaCI, 5 mM MgCI2,  1% Triton 
X-100, 0.1% BSA, 1% aprotinin, 100/~g/ml leupeptin, 10 #g/ml pepstatin, 
10 mM benzamidine, 10 ~g/ml soybean trypsin inhibitor. After centrifuga- 
tion at 16,000 g for 3 min, the resulting supernatants were brought to 500 
mM NaCI, 0.5%  deoxycholate, 0.05%  SDS, and precleared using 25 /zl 
(packed  volume)  of preimmune  serum  adsorbed protein A-Sepharose. 
R-Ras was then immunoprecipitated at 4°C for 0.5-1 h using 10/~1 of anti- 
R-Ras antiserum preadsorbed protein A-Sepharose. Immune complexes 
were washed eight times in 1 ml of 50 mM Hepes (pH 7.5), 500 mM NaCI, 
5  mM MgC12, 1%  Triton X-100,  0.005%  SDS.  Bound nucleotides were 
eluted in 2 mM EDTA, 2 mM DTT,  0.2%  SDS at 68°C for 20 min, and 
chromatographed on PEI-cellulose plates  in 0.75  M  KH2PO4  (pH  3.5) 
along with GDP and GTP standards (Sigma, Inc., St. Louis, MO).  Data 
were  analyzed by  autoradiography  and  quantifications were performed 
using a radioisotope detector system (Ambis-100). 
Raf-I Kinase Assays 
St9 cells were infected with recombinant baculoviruses (Reed et al., 1992; 
Xian-Feng  et  al.,  1993)  encoding  Raf-1,  Raf-l(259D),  Raf-1 (YY340, 
341FF), R-Ras, R-Ras(38V), Bcl-2, or various combinations of  these viruses, 
essentially as described (Wang et al., 1994).  After '~60 h, cells were lysed 
in 25 mM Tris (pH 8.0),  150 mM NaCI, 0.1% SDS, 0.5% Na-deoxycholate, 
1% NP-40, 10% glycerol, 2 mM EDTA,  1 mM Na-ortho-vanadate, 1 mM 
PMSF, 20 #M leupeptin, 5 #g/ml aprotirtin.  Raf-1 was then immunoprecipi- 
tated using protein A-Sepharose preadsorbed with an anti-Raf COOH- 
terminal peptide antiserum (Reed et al.,  1991b) and the resulting immune 
complexes washed twice with 20 mM Tris (pH 7.4),  150 mM NaC1,  1% 
Triton X-100,  10% glycerol, 2 mM EDTA,  1 mM Na-ortho-vanadate and 
protease inhibitors, before performing a final wash in kinase buffer (25 mM 
Hepes [pH 7.4],  150 mM NaC1, 25 mM glycerol phosphate, 1 mM DTT, 
5 mM MgCI2),  followed by incubation in 30 #1 of kinase buffer containing 
0.1-1  #g purified recombinant MEK protein,  10  #M  ATE  and 20 #Ci 
[32P]3,-ATP for 30 min at "~25"C.  The samples were then centrifuged at 
16,000 g for 1 min, and the supernatant containing MEK and the pellet con- 
taining Raf-1 immune complexes were separately size fractionated by SDS- 
PAGE. Phosphorylated MEK was detected by autoradiography in the dried 
gel, whereas Raf-1 was transferred to nitrocellulose and detected by immu- 
noblotting using anti-Raf-1 antibody, essentially as described (Wang et al., 
1994). 
Coimmunoprecipitation Assays 
Coimmunoprecipitation experiments were preformed as described previ- 
ously (Wang et al.,  1994) using polyclonai antisera and either transfected 
32D.3 cells or baculovirus-infected Sf9 cells. In addition, for some experi- 
ments, lysates were prepared from 2  ×  106 St9 cells in 0.25 ml of NP-40 
lysis buffer (10 mM Hepes [pH 7.5],  142.5 mM KCI, 5 mM MgC12, l mM 
EGTA, 0.2% NP-40, 0.2 mM PMSF, 5 #g/ml aprotinin, 0.7 #g/ml pepsta- 
tin, 5 #g/ml leupeptin) on ice for 0.5 h, and nuclei and cell debris were re- 
moved by centrifugation at 15,000 g for 15 min. After preclearing with 25 
#1  of protein G-Sepharose (Zymed Labs,  S.  San  Francisco,  CA),  im- 
munoprecipitations were performed using 2 #g of the 4D7 monoclonal anti- 
body (Reed et al.,  1992)  or a mouse IgGl control antibody (Dako, Inc., 
Carpinteria, CA) for 3 h at 4°C. Immune complexes were recovered using 
25 #1 Protein G-Sepharose, washed three times in lysis buffer, and subjected 
to SDS-PAGE/immunoblot assay using 0.1% vol/vol polyclonai anti-Raf-1 
or anti-R-Ras antisera followed by HRPase-donkey anti-rabbit (Amersham 
Corp., Buckinghamshire, England) and either colorimetric detection using 
3,Y-diaminobenzidine (DAB) or detection using an ECL system (Amer- 
sham Corp.). 
Results 
32D.3 cells are a murine myeloid progenitor cell clone that 
is  absolutely  dependent  on either  Interleukin-3  (IL-3)  or 
Granulocyte/Macrophage-Colony  Stimulating  Factor (GM- 
CSF) for proliferation and survival in vitro. These cells have 
a normal diploid karyotype  and, like freshly isolated bone 
marrow progenitors, retain the ability to undergo differentia- 
tion to mature granulocytes upon stimulation with appropri- 
ate lymphokines (Mavilio et al., 1989). Removal of IL-3 and 
GM-CSF  from cultures  of 32D.3  cells  results  in  G0-Gt- 
arrest followed by apoptosis. Because these cells have been 
used extensively as a model for investigations of mechanisms 
of programmed cell death  in the  setting of growth factor 
withdrawal  (for examples,  see references by Askew et al., 
1991; Nunez et al.,  1990;  Baffy et al.,  1993;  Wang et al., 
1994;  Cleveland et al.,  1994;  Ando et al.,  1993),  we em- 
ployed them for gene transfer studies of R-Ras. 
R-Ras Increases Rates of  Apoptotic Cell Death in 
IL-3-deprived 32D.3 Cells 
To study the effects of R-Ras alone and in combination with 
Bcl-2, 32D.3 cells were cotransfected with expression plas- 
mids encoding human Bcl-2 and either normal human p23- 
R-Ras  or a version of R-Ras  (gly~val  38) that contains a 
mutation analogous to the gly~val  12 mutation of activated 
Ha-Ras oncoproteins (Lowe and Goeddel,  1987). As a con- 
trol,  cells were also transfected  with the parental  vectors 
lacking R-ras or bcl-2 eDNA inserts ("32D-NEO"). In addi- 
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R-Ras(38V)  on  32D.3  cells 
survival  and  growth.  In  A, 
transfected  3213.3 cells  were 
cultured  at  10  ~  per  ml  in 
medium without 10% WEHI- 
3B conditioned medium as a 
source  of  IL-3.  At  various 
times thereafter,  the percent- 
age of viable cells  was deter- 
mined by counting cells in the 
presence of trypan blue dye. 
Data  represent  mean  +  SD 
(n--  3).  Symbols  repre- 
sent 32D-Neo cells (open cir- 
cles),  32D-Bcl-2 (closed  cir- 
cles),  32D-R-Ras(38V)  (open 
squares),  32D-R-Ras (closed 
squares),  32D-R-Ras(38V) 
+Bcl-2  (open  triangles), 
32D-R-Ras  +  Bcl-2 (closed 
triangles).  In  B,  transfected 
32D.3 cells were subeloned by 
limiting dilution and detergent 
lysates were prepared for im- 
mtmoblot analysis  (50 #g per 
lane) using anti-R-Ras antise- 
rum  (top panel).  The  posi- 
tions  of  the  endogenous 
mouse and transgene-derived 
human  R-Ras  proteins  are 
shown.  The  same  subclones 
were cultured  in the absence 
of IL-3 for 24 h and the per- 
centage of viable cells was de- 
termined by counting cells in 
the  presence  of trypan  blue 
dye (mean +  SD; n =  3) (bot- 
tom panel).  Clones represent 
32D.3  ceils  transfected  with 
the  following  plasmids: 
pEXV-R-Ras(38V)  +  pZip- 
Neo  (77-3-4  and  77-3-2); 
pEXV-R-Ras  +  pZip-Neo 
(77-4-5 and 77-4-1); pEXV-R- 
Ras(38V)  +  pZip-Bcl-2  (77- 
5-1) and pEXV-R-Ras + pZip- 
Bcl-2  (77-6-5).  In  C,  the 
subelones  77-1-1 (32D-Neo), 
77-3-4  (32D-R-Ras[38V]), 
77-2-1 (32D-Bcl-2), and 77-5-1 (32D-Bcl-2/R-Ras[38V]) were cultured at  105 cells  per ml in medium with (+) or without (-) 20% 
WEHI-3B conditioned medium for "o15 h. Cells were then fixed, permeabilized,  and treated  with RNAse before incubation  in 50/zg/ml 
propidium iodide (PI) and analysis by flow cytometry. Data represent  fluorescence  intensity  (abscissa)  vs relative cell number (ordinant). 
DNA contents  indicative  of apoptotic cells (Ao) and viable cells  in G0/G~, S, or Gz/M-phases  of the cell cycle are indicated. 
tion,  32D.3  cells  were  stably  cotransfected  with  various 
combinations of parental ("empty") vectors and plasmids en- 
coding  Bcl-2,  R-Ras,  or  R-Ras(38V)  to  express  Bcl-2  or 
R-Ras proteins individually rather than in combination. Af- 
ter selection in G418,  immunoblot analysis was performed 
on the resulting polyclonal bulk transfected cell lines,  con- 
firming  elevations  in  the  relative  levels  of R-Ras  (38V), 
R-Ras, and Bcl-2 proteins in the relevant transfectants but not 
in the 32D-NEO control cells (not shown). 
Transfected 32D.3 cells were washed to remove IL-3, and 
then  cultured  for various  times  in  medium  without  lym- 
phokines. Cell viability was assessed based on ability to ex- 
clude trypan blue dye. As shown in Fig. 1 A, 32D.3 cells ex- 
pressing  the  R-Ras(38V)  protein  died  with  accelerated 
kinetics  relative  to control-transfected  32D-NEO cells.  In 
the experiment shown, for example, only '~30% of 32D-R- 
Ras(38V)  cells  remained  viable at 24 h  after  factor with- 
drawal, compared to nearly 60% of 32D-NEO cells. At 36 h 
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alive compared to "~40  % of 32D-NEO cells. 32D.3 cells ex- 
pressing the normal R-Ras protein tended to die somewhat 
faster than control 32D-NEO cells, but the difference was not 
significant. Microscopic examination of  the dead cells under 
UV-illumination after staining with the DNA-binding fluoro- 
chrome DAPI demonstrated typical apoptotic morphology, 
including  condensed  chromatin,  fragmented  nuclei,  and 
shrunken  cell  size (not shown).  Consistent  with previous 
reports (Bal~ et al., 1993; Tanaka et al., 1993), expression 
of the  Bcl-2  protein  markedly  prolonged  the survival  of 
32D.3 cells in the absence of lymphokines, relative to con- 
trol 32D-NEO cells (Fig.  1 A). Coexpression of Bcl-2 also 
completely abrogated the effects  of  R-Ras(38V), such that the 
cell death kinetics of 32D-Bcl-2/R-Ras(38V) cells were es- 
sentially  superimposable  with  32D-Bel-2 cells.  Similar 
results were obtained in multiple experiments and by use of 
cells derived from two independent transfections. 
Analysis of  Independent Clones of Transfected 
32D.3 Cells Demonstrates Correlation of  Rates of 
Apoptosis with Levels of  R-Ras(38V) Protein 
To further examine the association between expression of 
the R-Ras(38V) protein and promotion of apoptosis, several 
independent clones of 32D.3 transfectants were obtained by 
limiting dilution and their relative levels of R-Ras proteins 
were determined by immunoblotting using a R-Ras-specific 
antiserum.  Clones  of  32D-R-Ras(38V)  and  32D-R-Ras 
transfectants with a wide range of R-Ras protein levels were 
found, presumably reflecting clonal variability in the geno- 
mic integration sites of  the R-Ras and R-Ras(38V) expression 
plasmids. Functional assessments of  these clones with regard 
to cell death rates in the absence of lymphokines demon- 
strated a clear correlation between higher levels of p23-R- 
Ras(38V) protein and faster cell death kinetics. Similarily, 
32D-cell  clones  expressing  higher  levels  of the  normal 
p23-R-Ras protein died at accelerated rates relative to clones 
that contained lower levels R-Ras, but the difference between 
high and low expressors was less striking than for the clones 
expressing the mutant activated R-Ras(38V) protein.  Fig.  1 
B shows representative results for a pair of high and low ex- 
pressing R-Ras(38V) and a pair of R-Ras-producing 32D.3 
cells, but similar results were obtained for multiple indepen- 
dent clones.  Also  shown are  typical  results  obtained for 
clones  that coexpressed  Bcl-2 and either R-Ras(38V) or 
R-Ras,  demonstrating  that  these  ceils  enjoyed  markedly 
prolonged  survival relative  to 32D.3 cells  that expressed 
R-Ras(38V)  or  R-Ras in  the  absence  of gene  transfer- 
mediated elevations in the levels of Bcl-2 protein. 
Next, flow cytometric analysis of propidium iodide (PI)- 
stained ceils was performed to measure the DNA content of 
various clones of transfected 32D.3 cells when cultured in 
the presence or absence of IL-3. When supplied with exoge- 
nous IL-3, clones of  transfected 32D.3 cells were distributed 
in all phases of the cell cycle. No significant differences in 
the proportions  of cells  in G0/G~, S, or G2/M-phases was 
observed among these transfectants, regardless of their rela- 
tive levels of R-Ras, R-Ras(38V), and Bcl-2 proteins. Fig. 1 
C, for example, presents results for some of the same sub- 
clones shown in Fig. 1 B that contained high levels of either 
p23-R-Ras(38V), p26-Bcl-2, or both of these proteins. The 
relative portion of 32D-R-Ras(38V) cells in G0/G~, S, and 
G2/M-phases was 47%, 20%, and 27%, respectively, com- 
pared to ranges of 40-43%  (G0/G0, 21-23%  (S), and 30- 
33%  (G2/M) among  32D-Bcl-2,  32D-Bcl-2/R-Ras(38V), 
and 32D-NEO cells. Thus, R-Ras did not significantly alter 
the cell cycle distribution of 32D.3 cells. When cultured for 
,x,1 d in the absence of IL-3, however, a large proportion of 
32D-R-Ras(38V)  cells  (~71%  in the experiment  shown) 
contained  hypodiploid  DNA  contents,  indicative  of the 
genomic digestion that occurs during apoptosis. The remain- 
ing presumably viable cells with normal DNA contents were 
distributed throughout the cell cycle, with 47 % in either S 
or  G2/M-phases.  Similarly,  32D-NEO  cells  experienced 
DNA degradation,  though in smaller proportions  (,x,41%), 
with 44 % of the remaining viable cells in either S or G2/M- 
phases.  In contrast,  32D.3 cells expressing high levels of 
Bcl-2 retained mostly normal DNA contents >95 %, regard- 
less of whether R-Ras(38V) protein was also present in the 
cells at high levels. Interestingly, fewer 32D-Bcl-2 and 32D- 
Bcl-2/R-Ras(38V) cells were found in S- or G2/M-phases at 
•1  d after IL-3 withdrawal (32-34%). 
Based on these observations, we conclude that R-Ras(38V) 
increases the rate of  cell death when 32D.3 cells are deprived 
of lymphokines through a mechanism consistent with apop- 
tosis as opposed to necrosis. R-Ras(38V), however, did not 
alter the cell cycle distribution of  32D.3 cells when cells were 
cultured with saturating amounts of  IL-3. Moreover, in addi- 
tional experiments not presented, the rate of  growth of 32D- 
R-Ras(38V)  clones  and  the  32D-R-Ras(38V) bulk  trans- 
fectants  in IL-3-containing medium was not appreciably 
different from the other transfectants during the first 2 d after 
initiation of cultures, based on determination of viable cell 
numbers by trypan blue dye exclusion. After 2 d, however, 
when IL-3 became limiting in the cultures, numbers of via- 
ble 32D-R-Ras(38V) cells began to fall precipitously, com- 
pared to other transfectants. Moreover, rates of [3H]thymi- 
dine  incorporation  into DNA  were  also  not different  for 
32D-R-Ras(38V) cells compared to other transfectants,  at 
least when measured at various times within the first day of 
initiation of cultures with optimal amounts of IL-3. These 
findings however do not exclude a potential role for R-Ras 
in  promoting  cell  proliferation  under  conditions  where 
suboptimal amounts of lymphokine are suppfied, analogous 
to the previously reported results for R-Ras(38V) in NIH- 
3T3 cells cultured in low serum (Cox et al., 1994). Finally, 
expression of R-Ras or R-Ras(38V) in 32D.3 cells did not al- 
ter their state of  differentiation, based on examination of  cell 
morphology  by Giemsa-Wright staining,  histostaining  for 
the presence of nonspecific esterase, and immunophenotyp- 
ing for Mac-1 and other cell surface markers (not shown). 
R-Ras(38V) Also Increases Rates of  Apoptotic Cell 
Death in Cultures of  lL-3-deprived FL5.12 Cells and 
Serum-deprived NIH-3T3 Fibroblasts 
To determine whether the ability of R-Ras(38V) to increz~e 
rates  of cell  death  in the  absence  of growth  factors  was 
unique to 32D.3 cells or more broadly applicable, we evalu- 
rated the effects of R-Ras(38V) on apoptosis induced by IL-3 
deprivation in FLS.12 cells and by serum withdrawal in NIH- 
3T3 cells. For these experiments, FLS.12 and NIH-3T3 cells 
were transfected with expression plasmids encoding R-Ras 
(38V) or the same parental vector lacking R-Ras as a control 
(Neo). Some cells were also transfected with a Bcl-2 expres- 
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Bcl-2 expression plasmid but not in other transfected NIH- 
3I"3 and FL5.12 cells (Fig. 2 B and data not shown). Evaluation 
of the  relative levels of the  mitochondrial protein  F~-/% 
ATPase served as a  control, verifying loading of approxi- 
mately equal amounts of total protein in all lanes (Fig. 2 B 
and data not shown). 
These NIH-3T3 cells were then cultured for 2 d in the ab- 
sence of serum,  and cell viability was  assessed by DAPI 
staining  to  distinguish  apoptotic cells  from cells that  re- 
tained normal nuclear morphology. As shown in Fig. 2 A, 
~70-80% of R-Ras(38V)-producing NIH-3T3 cells had un- 
dergone apoptosis after 2 d without serum growth factors, 
compared to only ,~,40--50%  of  Neo control  cells.  In con- 
trast,  relatively  few of  the  NIH-3T3 ceils  that  coexpressed 
R-Ras(38V)  and  Bcl-2  had  become apoptotic  (<20%). Simi- 
larly,  the  kinetics  of  ceil  death  were  markedly  accelerated  in 
cultures  of IL-3-deprived R-Ras(38V)-expressing  FL5.12 
cells compared to 32D-NEO control cells. Conversely, FL5.12 
cells that contained high levels of Bcl-2 protein survived for 
prolonged periods in the absence of IL-3 (Fig. 2 C). These 
findings indicate that R-Ras(38V)  can also increase the rate 
of cell death in serum-deprived NIH-3T3 cells and lympho- 
kine-starved FL5.12 cells. 
Figure 2. Immanoblot and fimctional analysis of transfected Nil-I- 
3"I"3 and FL5.12 cells. In A, transfected 32"3 cells were seeded at 
5  x  104 cells per well of 24-well plates. The following day, cells 
were cultured for "~48 h without serum and the cells were stained 
with DAPI. The percentage apoptotic cells was then determined, 
counting ~800 cells per sample (mean + SD In ffi 3]). In B, stably 
transfected NIH-3T3 cells were analyzed by immunoblotting (50 #g 
total protein per lane) using antibodies specific for R-Ras, Bcl-2, 
or Fm-~-ATPase. The positions of the endogenous mouse R-Ras 
and Fr~-ATPase proteins are indicated, as well as the transgene- 
derived human R-Ras and Bcl-2. In C, stably transfected FL5.12 
cells were cultured at I06 cells/ml in medium without IL-3. The 
percentage of viable cells was determined at various times there- 
after by trypan blue dye exclusion (mean +  SD; n  --  3). In D, 
detergent-lysates were prepared from G418-resistant FL5.12 cells 
that had been stably transfected with Neo-control, R-Ras(38V), or 
Bcl-2 expression plasmids. Proteins (50/~g/lane) were subjected to 
SDS-PAGE/immunoblot assay using anti-R-Ras antiserum. 
sion vector or were cotransfected with R-Ras(38V)  and Bcl-2 
expression plasmids.  Immunoblot analysis  confirmed the 
production of the human R-Ras(38V)  protein, in addition to 
the endogenous mouse R-Ras  protein,  in  those  NIH-3T3 
cells that received the R-Ras(38V) expression plasmid but 
not in the control (Neo) transfected cells (Fig. 2 B). Levels 
of  p23-R-Ras  protein  were  also  markedly  elevated  in 
R-Ras(38V)-transfected FLS.12 cells, compared to FLS.12 
cells that received either the Neo-control plasmid or a Bcl-2 
expression plasmid  (Fig.  2  D).  Human Bcl-2 protein was 
Bcl-2 Abrogates R-Ras-pmmoted Cytotoxicity 
without Altering GTP Binding or GTPase Activity of 
R-Ras Proteins 
The ability of Bcl-2 to completely abrogate the effects of 
R-Ras(38V)  and R-Ras on cell death induced by factor with- 
drawal raised the possibility that Bcl-2 nullifies some bio- 
chemical function of the R-Ras protein, particularly since 
Bcl-2 and R-Ras have been reported to physically interact 
based on yeast two hybrid experiments and coimmunopre- 
cipitation  assays  (Ferendez-Sarabia and  Bischoff,  1993). 
One of the mechanisms by which Bcl-2 could potentially in- 
terfere with R-Ras function is by either accelerating the rate 
of hydrolysis of  bound GTP, analogous to GTPase-activating 
proteins, or by inhibiting GDP/GTP-exchange and thus leav- 
ing R-Ras in an inactive GDP-bound state. 
To begin to examine these possibilities, R-Ras and R-Ras 
(38V)  were expressed in E.  coli as GST-fusion proteins, 
affinity purified, and loaded with p2p]7-GTP. The GST-R- 
Ras  protein  hydrolyzed GTP to  GDP  in  vitro such  that 
",,35-40% of  the total GTP was converted to GDP within 30 
min. As expected, but never before confirmed in the litera- 
ture, the GST-R-Ras(38V) protein exhibited no GTPase ac- 
tivity under these conditions. Addition of ~0.5 ~,g of  purified 
baculovirus-produced Bcl-2 protein to these reactions had 
no influence on R-Ras or R-Ras(38V)  GTPase activity (Fig. 
3 A). Similar results were obtained using two independent 
preparations of immunoaffinity-purified Bcl-2 protein (not 
shown). Bcl-2 protein prepared in this same manner has been 
shown to be biologically active, based on experiments using 
a cell-free assay for apoptosis (Newmeyer et ai.,  1994) and 
on electmporation of Bcl-2 protein into human B-cell lines 
(Haldar et al.,  1994).  Thus, at least when tested in vitro 
using purified proteins, Bcl-2 did not directly modulate the 
GTPase activity of  the R-Ras or R-Ras(38V) proteins. In pre- 
liminary experiments, recombinant Bcl-2 protein also ap- 
peared to have no GDP/GTP-exchange activity on GDP- 
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the experiment presented in Fig. 3 B, for example, the per- 
centage of bound GTP relative to total associated guanine 
nueleotides (GDP  +  GTP) was  82%  and 78%  for 32D- 
R-Ras(38V) and 32D-Bcl-2/R-RasOSV) cells, respectively. 
Immune complexes prepared from these cells also contained 
essentially  equivalent  amounts  of  R-Ras  proteins  (not 
shown).  We conclude therefore that Bcl-2 does not block 
R-Ras(38V)- mediated effects on apoptotic cell death by al- 
tering the relative amounts or proportions of GTP-bound to 
R-Ras proteins. 
Figure 3. Effects of  Bcl-2 on R-Ras GTPase activity and GTP bind- 
ing. In  A,  GST-R-Ras (circles) and  GST-R-Ras(38V) proteins 
(squares) were loaded with [32p],y-GTP  and incubated with (dark 
symbols) or without (open  symbols) 0.5 ttg of  affinity-purified  Bcl-2 
protein.  Reactions were initiated by placing samples at 30°C. At 
various times thereafter, aliquots of samples were filtered.through 
nitrocellulose, washed, subjected to scintillation counting, and the 
percentage of [32P]7-GTP  remaining was calculated relative to To. 
Results for GST nonfusion protein are also shown as a negative con- 
trol, where the data are calculated relative to GST-R-Ras(38V) at 
To.  Data  are  representative  of two experiments.  In B,  32D-R- 
Ras(38V) cells (lane 1 ) and 32D-R-Ras(V38)+Bcl-2 cells (lane 2) 
were  metabolically  labeled  with  3~PO4. Detergent lysates were 
prepared from 107 ceils, and R-Ras was immunoprecipitated. As- 
sociated  nucleotides  were  eluted  from immune complexes and 
chromatographed on PEI-cellulose along with GTP and GDP stan- 
dards. Filters were subjected to autoradiography and the positions 
of [32P]GTP and [32p]GDP indicated. Data are representative of 
two experiments. 
loaded GST-R-Ras and GST-R-Ras(38V) proteins in vitro 
(not shown). However, several exchange proteins, including 
Sos  (Buday  and  Downward,  1993),  cdc25,  and  Vav  also 
failed to catalyze GDP/GTP-exchange on GST-R-Ras and 
GST-R-Ras(38V), while some of these (Sos and cdc25) were 
effective on GST-Ha-Ras. Thus, we cannot completely dis- 
count  the possibility  that  Bcl-2  might  have exhibited  ex- 
change activity had alternative conditions for these in vitro 
assays been tried, but nevertheless consider it unlikely. 
Though Bcl-2 had no GAP or GDP/GTP-exchange  activity 
on R-Ras in vitro, these results do not exclude the possibility 
that Bcl-2 could modulate the ratio of GTP/GDP bound to 
R-Ras protein in cells through indirect effects on other pro- 
teins that control R-Ras GTPase activity or nucleotide ex- 
change. Since Bcl-2 can completely abrogate the cell death 
promoting activity even of the mutant  R-Ras(38V)  which 
lacks detectable GTPase activity, we compared the ratio of 
GTP/GDP bound to R-Ras(38V)  in  32D.3  cells that con- 
tained  normal  levels of Bcl-2  protein vs those with gene 
transfer-mediated elevations in the relative amounts of Bcl-2 
protein. For these experiments, 32D-R-Ras(38V) and 32D- 
Bcl-2/R-Ras(38V)  cells  were  metabolically  labeled  with 
32PO4. R-Ras proteins were then immunoprecipitated from 
these cells and the relative amounts of GTP and GDP as- 
sociated with immune complexes were determined by thin 
layer chromatography.  Both  the  total  amount  of guanine 
nucleotides and the relative proportions of GTP and GDP as- 
sociated with R-Ras proteins were not significantly different 
Investigations of  Bcl-2 Effects on R-Ras Interactions 
with Raf-1 Kinase 
Recently, R-Ras has been shown to bind to Raf-1 kinase in 
vitro based on experiments employing purified recombinant 
proteins and in yeast two hybrid experiments (Rey et al., 
1994;  Spaargaren et al.,  1994).  Presumably the region in 
R-Ras required for interaction with Raf-1 corresponds to the 
presumptive effector domain of this GTPase (residues 51 to 
72), which shares significant amino acid sequence homology 
with the effector domain of Ha-Ras where Raf-1 binds, in- 
cluding 9 of 9 residue identities in the core of this domain 
(amino acids 58-66) of R-Ras (32-40 of Ha-Ras) (Lowe and 
Goeddel, 1987; Selfet ai.,  1993; Zhang et al.,  1993). Like 
Ha-Ras, the interaction of R-Ras with Raf-1 is dependent on 
R-Ras being in the GTP-bound state (Rey et al., 1994; Spaar- 
garen et al., 1994). Using recombinant baculoviruses, Raf-1 
was  coexpressed in  Sf9 cells with either R-Ras or R-Ras 
(38V).  Coimmunoprecipitation  experiments  showed  that 
Raf-1 associated with R-Ras(38V) and to a lesser extent with 
the normal R-Ras protein (not shown), consistent with the 
GTP dependence of R-Ras/Raf-1  interactions. Coexpression 
of R-Ras(38V) but not R-Ras also resulted in elevations in the 
specific activity of  the Raf-1 kinase in St9 cells, based on im- 
mune complex kinase assays where Raf-1 was immunopre- 
cipitated and assayed for ability to phosphorylate recom- 
binant purified MEK protein in vitro (Fig. 4).  These data 
thus provide the first direct demonstration that R-Ras(38V) 
can promote Raf-1 kinase activation. Since these Raf-1 im- 
mune complexes were prepared under conditions that do not 
preserve in vitro interactions with R-Ras (not shown), pre- 
sumably R-Ras(38V) induced activation of Raf-1 in St9 cells 
by bringing it into contact with Raf-1 kinases or other Raf- 
activating proteins that are associated with membranes in 
Sf9 cells (Leevers et al.,  1994; Stokoe et al.,  1994). Next, 
the effects of Bcl-2 on R-Ras-mediated activation of Raf-1 ki- 
nase were explored in the St9 cells to determine whether 
Bcl-2 is capable of blocking this R-Ras effector mechanism. 
As shown in Fig. 4, expression of Bcl-2 in Sf9 cells did not 
interfere with R-Ras(38V)-induced elevations in  Raf-1 ki- 
nase activity.  Approximately equivalent amounts  of Raf-1 
protein were produced in all Sf9 samples, excluding varia- 
tions in the levels of Raf-1 protein as an explanation for the 
higher levels of Raf-1 kinase activity seen in R-Ras(38V)- 
containing Sf9 cells (bottom panel;  Fig. 4). 
Analysis of  R-Ras Interactions with Bcl-2 by 
Coimraunoprecipitation Assays 
To begin to examine the physical interactions among R-Ras, 
Raf-1,  and  Bcl-2 proteins,  coimmunoprecipitation experi- 
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St9  cells.  Sf9  cells  were  infected  with  various  recombinant 
baculoviruses, including: (lane 1 ) Raf(259D), a constitutively ac- 
tive  form of Raf-I kinase  used  as  a  positive  control;  (lane 2) 
Raf(Y340F, Y341F), an inactive form of Raf-I kinase used as a 
negative control; (lane 3) normal Raf-1 kinase; (lane 4) Raf-1 and 
Bcl-2; (lane 5) Raf-I and R-Ras(38V); (lane 6) Raf-1, R-Ras(38V), 
and Bcl-2; (lane 7) Raf-I and R-Ras; and (lane 8) Raf-1, R-Ras, and 
Bcl-2. 2 d later, cells were lysed in RIPA buffer and Raf-I kinase 
was immunoprecipitated. The resulting immune complexes were 
employed for in vitro kinase assays using MEK as an exogenous 
substrate and [32p]3,-ATP. Reactions were centrifuged to separate 
MEK protein (supematant;  top panel) and Raf-1 immune com- 
plexes (pellet;  bottom panel).  Proteins were size fractioned by 
SDS-PAGE and the resulting gels either dried for autoradiographic 
detection of  phosphorylated MEK (top) or transferred to nitrocellu- 
lose and incubated with anti-Raf-I antiserum to compare relative 
levels of Raf-1 protein (bottom). The production of high levels of 
Bcl-2 and R-Ras proteins was also verified by immunoblot analysis 
of a portion of the cell lysates (not shown). 
ments were performed using recombinant baculoviruses so 
that high levels of these proteins could be produced in St9 
cells, thus facilitating detection of protein-protein associa- 
tions. When St9 cells were coinfected with Bel-2 and either 
R-Ras or R-Ras(38V), and then cell lysates were subjected 
to immunoprecipitation using anti-R-Ras antibody, little or 
no associated Bel-2 protein was detected by subsequent im- 
munoblotting using anti-Bcl-2 antibodies (see Fig. 5 A; lane 
5; and data not shown). Under these same experimental con- 
ditions where essentially no association of Bcl-2 with either 
R-Ras  or  R-Ras(38V)  was  seen,  Raf-1  kinase  was  coim- 
munoprecipitated with R-Ras or R-Ras(38V) at easily detect- 
able levels (representing ,~10--20% of total Raf) from either 
St9 cells coinfected with Raf-1 and R-Ras alone or cells triply 
infected with Bcl-2, Raf-1, and R-Ras (Fig. 5 A; lanes I  and 
2; and data not shown). Similar results were obtained when 
anti-Bcl-2 antibodies were employed for immunoprecipita- 
tions and immunoblotting was performed with anti-R-Ras 
antibodies. As shown in Fig. 5 B, for example, very little 
R-Ras was coimmunoprecipitated with Bcl-2 from St9 cells 
that had been infected with the combination of either Bcl-2 
and R-Ras(38V)  baculoviruses (lanes 1 and 2). Direct immu- 
noblot analysis of an aliquot of these same lysates confirmed 
the presence of high levels of R-Ras(38V) protein, excluding 
failure to produce R-Ras(38V)  as an explanation of the mini- 
mal amounts of  this protein that could be recovered with Bcl- 
2 immune complexes (Fig. 5 B, lane 3).  Performing triple 
infections with Bcl-2, Raf-1, and either R-Ras or R-Ras(38V) 
baculoviruses did not change the results, though in some ex- 
periments slightly more Bcl-2 could be coimmunoprecipi- 
tated with R-Ras when Raf-1 was added (not shown). In addi- 
tion, in yeast two hybrid assays,  no significant interaction 
above background of R-Ras or R-Ras(38V)  with Bcl-2 was 
detected, when using fusion proteins that lacked the CAAX 
boxes of R-Ras and R-Ras(38V)  and the transmembrane do- 
main of Bcl-2 so as not to interfere with nuclear targeting. 
Under these  same  conditions,  however,  R-Ras  and  R-Ras 
(38V) did strongly interact with Raf-1 (unpublished observa- 
tions). 
R-Ras(38V) and R-Ras Do Not Coimmunoprecipitate 
with Bax 
The finding that R-Ras promotes apoptotic death of 32D.3 
ceils in the setting of factor deprivation prompted us to ex- 
plore the possibility of an association between R-Ras and 
Bax, a protein that shares 21% amino acid sequence homol- 
ogy with Bcl-2, forms heterodimers with Bcl-2, and acceler- 
ates rates of cell death in IL-3-dependent hematolymphoid 
cells when these cells are cultured in the absence of lym- 
phokines (Oltvai et al., 1993). For these experiments, 32D.3 
cell transfectants were lysed using gentle detergent condi- 
tions (0.2 % NP-40) and immune complexes were prepared 
using antibodies specific for either Bax or R-Ras. The result- 
ing immune complexes were then assessed for associated 
R-Ras,  Bax,  and Bcl-2 proteins by immunoblot assay.  As 
shown in Fig. 6, no Bax was detected in anti-R-Ras immuno- 
precipitates.  Similarly  no detectable R-Ras  was  observed 
anti-Bax immune complexes (not shown). Conversely, Bcl-2 
was coimmunoprecipitated with Bax. Thus, if  R-Ras does in- 
teract with Bax, it presumably does so with lower affinity or 
with lower stoichiometry than Bcl-2/Bax interactions. More- 
over, in yeast two hybrid assays, no interaction of R-Ras or 
R-Ras  (38V)  (expressed without  CAAX  boxes)  with  Bax 
(without  its  transmembrane  domain)  was  detected  above 
background, whereas Bcl-2 and Bax did interact strongly in 
these experiments (unpublished observations). 
We also could not detect Bcl-2 associated with immune 
complexes prepared with anti-R-Ras antibodies from 32D.3 
cell lysates (Fig. 6), consistent with the data presented above 
for St9 ceils. R-Ras(38V)  and R-Ras also did not detectably 
coimmunoprecipitate with Bcl-2 when anti-Bcl-2 antibodies 
were used for immunoprecipitation (not shown). 
Discussion 
R-Ras has been reported to interact with the Bcl-2 protein, 
thus suggesting a role for this GTPase in the regulation of 
physiological  cell  death  pathways  (Ferendez-Sarabia  and 
Bischoff, 1993). Here we show for the first time that an acti- 
vated version of R-Ras can increase the rate of apoptotic cell 
death in the setting of growth factor withdrawal and that Bcl- 
2 completely abrogates this effect of R-Ras.  The mechanism 
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of R-Ras interactions with Bcl-2 and Raf-1 
in Sf9 cells. In A, Sf9 ceils were coinfeeted 
with  either  Raf-I  and  R-Ras recombinant 
baculoviruses  (lanes 1, 2, and 6) or Bel-2 
and R-Ras (lanes 3-5,  7).  Approximately 
60 h later, detergent lysates (0.2% NP-40) 
were  prepared  and  immunoprecipitations 
were performed using 200/zl of lysate and 
5-10/~1 of anti-R-Ras  antiserum  (lanes 2 
and  5),  anti-Bel-2  antiserum  (lane  4), 
anti-Raf-1 antibody (lane 1 ) or normal rab- 
bit antiserum as a negative control (lane 3). 
In addition to immune complexes, 15/zl of 
the Sf9 cell lysates were applied directly to 
the gel without immunoprecipitation (lanes 
6 and 7). Proteins were subjected to SDS- 
PAGE  and  transferred  to  nitrocellulose 
filters which were incubated with antisera 
specific for Raf-1 (top half) or Bcl-2 (bot- 
tom ha/f) and  detected  by ECL method. 
The bands seen at ,x,50 kD in lanes 1-5 rep- 
resent rabbit immunoglobulin heavy chain 
proteins derived from the immunoprecipi- 
tations. In B, Sf9 ceils were coinfected with 
Bcl-2 and R-Ras(38V) recombinant baculo- 
viruses,  and  immunoprecipitations  were 
performed  using  either  the  anti-Bcl-2 
monoclonal  antibody  4D7  (Reed  et  al., 
1992)  or  IgG1 control  antibody  (CNTL) 
(lanes 1 and 2).  Immune complexes were 
subjected to SDS-PAGE immunoblot analysis using anti-R-Ras antiserum.  An aliquot of the Sf9 cell lysates equivalent to 8 % of that used 
for coimmunoprecipitation  experiments was run directly in the gel, to verify production of R-Ras protein (lane 3). Antibody detection 
was by a diaminobenzidine  colorimetric  method.  Similar results were obtained using ECL for detection (not shown). 
by which Bcl-2 nullifies R-Ras effects on cell death was ex- 
arnined with regards to R-Ras GTP-binding and GTPase ac- 
tivity. Bcl-2 did not affect R-Ras GTPase activity nor did it 
act as an exchange protein for R-Ras in vitro. Though we can- 
not exclude the possibility that Bcl-2 indirectly regulates the 
activity of R-Ras through effects on R-Ras GAPs or GDP ex- 
change proteins in cells, this does not appear to provide an 
explanation for how Bcl-2 abrogates R-Ras effects on cell 
death. In 32D.3 cells, for example, R-Ras(38V) bound GTP 
to the  same extent regardless of whether  Bcl-2 was over- 
produced. Thus, Bcl-2 did not prevent R-Ras(38V) from as- 
suming an active GTP-bound state. The implication of this 
finding is that Bcl-2 lies downstream of R-Ras in a cell death 
pathway, and is able to nullify the effects of R-Ras on growth 
factor withdrawal-induced  apoptosis even when R-Ras as- 
sumes an active GTP-bound conformation. 
How then does Bcl-2 interfere with R-Ras(38V)-mediated 
effects on apoptotic cell death? One possibility is that Bcl-2 
somehow interrupts the interaction of activated GTP-bound 
R-Ras with a downstream effector protein. Based on the data 
presented  here  showing  that  coexpression  of R-Ras(38V) 
with Raf-1 in St9 cells leads to elevations in Raf-1 kinase ac- 
tivity (Fig. 4), Raf-1 appears to be one potential downstream 
effectors of R-Ras.  In this  regard,  Cox et al.  (1994)  have 
shown that expression of an activated form of R-Ras in NIH- 
3T3 cells leads to increased phosphorylation of IM4-ERK-1 
and p42-ERK-2 and that a  dominant inhibitory  mutant of 
Raf-1  that lacks kinase activity inhibits  R-Ras-induced in- 
creases in activity of a ms-responsive promoter. Moreover, 
Raf-1 kinase has been shown to bind to R-Ras in vitro and 
in yeast two hybrid assays in a GTP-dependent manner (Rey 
et al.,  1994;  Spaargaren et al.,  1994),  but not to a mutant 
form of R-Ras that contains a serine 43 to asparagine amino 
acid substitution which is analogous to a Asnl7 dominant- 
inhibitory form of Ha-Ras (Spaargaren et al., 1994). The re- 
gion within Raf required for interaction with R-Ras corre- 
sponds to a  segment within the NH2-regulatory domain of 
Raf-1 (amino acids 51-131) that also is necessary for interac- 
tions with Ha-Ras (Vojtek et al.,  1993).  Conversely, the re- 
gion in Raf that is sufficient for binding to Bcl-2 resides in 
the carboxyl-half of this protein, where the kinase domain 
is located (Wang et al.,  1994). Consistent with the mapping 
of the  Ras-binding  and  Bcl-2-association  domains  within 
Raf-1 to distinctly different domains, coproduction of Bcl-2 
protein in Sf9 cells with R-Ras(38V) and Raf-1 did not pre- 
vent R-Ras(38V) from inducing increases in Raf-1 kinase ac- 
tivity (Fig. 4). Bcl-2 also did not detectably diminish coim- 
munoprecipitation of R-Ras(38V) and Raf-1 when the three 
proteins were simultaneously produced in St9 cells (unpub- 
lished  observations).  Thus,  it  seems  unlikely  that  Bcl-2 
thwarts  the  effects  of  R-Ras  on  cell  death  by  blocking 
R-Ras-mediated activation of Raf-1  kinase,  but  additional 
work must be done before this possibility can be completely 
excluded.  It should be noted,  however,  that Raf-1  may be 
only one of several potential downstream effectors of R-Ras, 
given that Ha-Ras has been shown to interact with Raf-1, 
phosphatidylinositol-3'-kinase, NF1-GAP and p120 ras-GAP 
via its effector domain (Vojtek et al.,  1993;  Zhang et al., 
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tation analysis of R-Ras inter- 
actions with Bax and Bcl-2 in 
32D.3 cells. Detergent lysates 
(0.2% NP-40) were prepared 
from  various  transfected 
32D.3  cells  (10  7  cells)  and 
immunoprecipitations  were 
performed  using  preimmune 
rabbit  serum  as  a  negative 
control  (lane 1),  anti-R-Ras 
antiserum  (lane  2),  or  anti- 
Bax antiserum (lane 3).  Im- 
mune  complexes  were  sub- 
jected  to  SDS-PAGE and 
transferred  to  nitrocellulose. 
The resulting blots were  in- 
cubated sequentially with an- 
tibodies specific for Bcl-2 (top 
panel), followed by Bax (bot- 
tom panel).  Antibodies were detected by an ECL method.  Blots were stripped of the previous antibody using 2%  SDS, 0.1  M 2- 
mercaeptoethanol, 62.5 mM Tris (pH 6.7) at 50°C for 0.5 h. The positions of the endogenous mouse Bax and transgene-derived human 
Bcl-2 proteins arc shown. 
1993; Rodriguez-Viciana et al., 1994; Frech et al., 1990) and 
that the effector domains of Ha-Ras and R-Ras have either 
identical or closely related amino acid sequences, depending 
on how this domain is defined (Lowe and Goeddel,  1987; 
Rey et al.,  1994).  Consequently,  it remains possible that 
Bcl-2 directly interferes with the interaction of R-Ras with 
some other unknown downstream effector that regulates a 
signal transduction pathway involved in apoptosis. 
Any model that attempts to position Bcl-2 as a direct inhib- 
itor of R-Ras, however, must take into consideration the poor 
efficiency  with which these proteins could be coimmunopre- 
cipitated from transfected 32D.3  and baculovirus-infected 
St9 cells. Our virtual inability to coimmunoprecipitate Bcl-2 
and R-Ras differs from a report by Fernandez-Sarabia and 
Bischoff (1993) where Bcl-2 and R-Ras were coimmunopre- 
cipitated from HeLa cells in which overproduction of these 
proteins was achieved by gene transfection. Though a variety 
of technical issues may account for the differences in our 
results, we were able to readily coimmunoprecipitate R-Ras 
and Raf-1 from St9 cells and we also could easily coim- 
munoprecipitate Bax and Bcl-2 from 32D.3 cells, under the 
same  conditions  where  Bcl-2  and  R-Ras  were  coim- 
munoprecipitated minimally, if at all. These findings there- 
fore argue that the binding of R-Ras and Bcl-2 may occur 
with low affinity or low stoichiometry, compared to interac- 
tions of R-Ras with Raf-1 and of Bcl-2 with Bax. Alterna- 
tively, it is possible that an additional unknown third protein 
is required to facilitate interactions of R-Ras with Bcl-2 or 
that this protein-protein interaction is modulated by post- 
translational modifications that failed to occur in our 32D.3 
or Sf9 ceils. Finally, we cannot exclude the possibility that 
transient interactions of Bcl-2 with R-Ras can occur, which 
are somehow dependent on whether or not guanine nucleo- 
tides are bound to R-Ras. 
In contrast to activated RoRas which accelerated the rate 
of 32D.3 cell death when cultured without IL-3, expression 
of v-raf in  32D.3  cells  has  been  reported to  delay  pro- 
grammed  cell  death  caused  by  lymphokine  withdrawal 
(Cleveland et al.,  1994).  Moreover, whereas  32D.3  cells 
cotransfected with R-Ras(38V)  and Bcl-2 exhibit cell sur- 
vival  kinetics  comparable to  cells transfected with  Bcl-2 
alone, 32D.3 cells coexpressing Bcl-2 and an activated ver- 
sion of c-raf-1 enjoyed markedly prolonged survival relative 
to cells expressing Bcl-2 alone (Wang et al.,  1994).  Thus, 
Raf-1 can cooperate with Bcl-2 to provide enhanced protec- 
tion from apoptosis  caused by growth  factor deprivation. 
Since R-Ras can induce Raf-1 activation, these observations 
suggest a potential paradoxical situation where activated Raf- 
1 kinase can prolong cell survival in one scenario, but then 
possibly accelerate cell death in another. However, we do not 
know whether the mechanism that R-Ras uses to increase 
rates of cell death involves Raf-1 vs some other downstream 
effector  protein. Also, it is possible that Raf-1 can have differ- 
ent effects on apoptosis depending on the substrates to which 
it is targeted by its interactions with various proteins such as 
R-Ras,  Ha-Ras, and Bcl-2. 
The increased rates of cell death seen in IL-3-deprived 
32D.3 cells that contain R-Ras(38V)  is reminiscent of previ- 
ous results obtained for Myc oncoproteins, which have been 
shown to promote apoptosis in 32D.3 and other cells when 
deprived of growth factors (Askew et al.,  1991; Evan et al., 
1992).  Under circumstances where growth factors are ab- 
sent but c-Myc remains elevated, a clash in cell cycle signals 
occurs, resulting in the triggering of apoptosis via a mecha- 
nism that is suppressible by Bcl-2 (Bissormette et al.,  1992; 
Fanidi et al., 1994). In this regard, activated R-Ras has been 
reported to promote growth of NIH-3T3 cells in reduced se- 
rum, suggesting an effect on cell cycle (Cox et al.,  1994). 
Despite some similarities, however, R-Ras and Myc clearly 
perform distinct biological functions, since coexpression of 
R-Ras(38V) and Bcl-2 in IL-3-dependent cells did not result 
in factor-independent growth, unlike coexpression of Myc 
and Bcl-2 which does (Vaux et al.,  1988). Also of interest 
with regards to the proapoptotic effects of R-Ras on factor- 
deprived cells are studies showing that oncogenic Ha-Ras 
can accelerate rates of apoptosis in murine fibroblasts when 
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radiation or chemotherapeutic drugs (Tanaka et al.,  1994). 
Thus, R-Ras may share some characteristics in common with 
Ha-Ras with regards to sensitizing cells to apoptosis. Fur- 
ther work is required therefore to delineate the mechanisms 
by which R-Ras accelerates apoptotic cell death in growth 
factor-deprived cells and yet can also promote anchorage- 
independent growth in vitro and tumor formation in vivo, at 
least for some types of cells such as NIH-3T3  fibroblasts 
(Cox et al.,  1994;  Saez et al.,  1994).  Regardless of these 
mechanisms, the data shown here argue that this R-Ras- 
mediated pathway for apoptosis is ultimately governed in a 
dominant fashion by Bcl-2. 
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